INTRODUCTION
============

The pivotal role of sleep seems forsaken. An adult should sleep at least 7 hours per night for a good health, although there are short and long-sleepers^[@r1]^. Sleep disturbances, such as insomnia,^[@r2]^ obstructive sleep apnea (OSA)^[@r3]^, and *shift work* disturbances^[@r4]^ decrease sleep quality and may generate sleep deprivation, which is ubiquitous among health-care providers. It may be classified as acute continuous or chronic partial (i.e., insufficient recovery sleep)^[@r5]^. The former presents dose-dependent deterioration in motor skills, mood and cognitive abilities, equivalent to a blood alcohol concentration of 0.004% rise per hour^[@r5]^. The latter generates depressed mood, attention and cognitive impairments, which may be seen after less than 6 hours of sleep per night in less than 2 weeks; it is equivalent to 24 hours of sleep deprivation. Subjects perceive they become adapted to sleep loss, but impairment tends to increase^[@r5]^. Given the importance of good sleep in synapse consolidation in the hippocampus and neocortex^[@r6],[@r7]^ memory is one of the most affected features in human health, which may diminish academic performance.

Medical students are exposed to poor sleep, due to high work and study loads, overnight shifts, and emotionally challenging duties^[@r8]^. Recent evidence suggests they tend to sleep less than 6 hours per night^[@r9],[@r10]^. These factors may reduce academic performance, trigger mental health issues and have a negative impact on the performance of health-care systems^[@r8]^. Chang *et al* reported a prevalence of 66% of depressive symptoms and more than 50% of burnout syndrome in medical students^[@r11]^. Dyrbye et al.^[@r12]^ showed this syndrome undermines professional attitudes towards patients, facilitates dishonest behaviors, and diminishes altruistic values regarding physician\'s responsibility to society. Its relationship with sleep deprivation was shown by Söderström et al.^[@r13]^

Given the rising importance of sleep disturbances in public health, this subject has been approached in medical students all over the world with staggering results^[@r8]^. Sleep problems, such as insomnia and difficulty initiating and maintaining sleep, are frequent in college students^[@r14]^. Emotional distress has been reported to mediate these alterations^[@r15]^. For instance, anxiety is associated with a higher frequency of nightmares, and those students reporting a higher frequency tend to rate sleep quality as poorer^[@r16]^ This combination may lead to an increase risk of psychological and learning problems^[@r17],[@r18]^ which may be buffered through psychological interventions that improve sleep^[@r19]^.

Further, reports in medical students in Saudi Arabia^[@r20]^ and Germany^[@r21]^ showed a prevalence of 36% of daytime sleepiness using the Epworth Sleepiness Scale (ESS), and 59% of poor sleep quality using the Pittsburgh Sleep Quality Index (PSQI), respectively. Similar results were described in Estonian^[@r22]^ and Iranian studies^[@r23]^. However, reports from Latin America seem worse. Poor sleep quality may reach 88%^[@r24]^ and daytime sleepiness may be as high as 60%^[@r25],[@r26]^.

Equally important, differences in circadian rhythmic expression between individuals promote circadian preferences, known as morningness-eveningness, which further influence students sleep patterns^[@r27],[@r28]^. Evening-type students appear to present a higher risk for depressive mood, suicidal ideations and substance abuse^[@r29]^ although its impact in academic performance is conflicting: a study in the United States reported worse performance in evening-type students^[@r27]^, but a Colombian study did not find differences^[@r9]^. Thus, sleep disturbances impact academic performance and mental health, drawing attention to the possible benefits of screening and targeted interventions for medical students with sleep disturbances, as these issues may turn our population prone to substance abuse and mental illnesses^[@r8]^. This information will be pivotal for curricula modifications worldwide.

The aim of our study was to determine sleep disturbances using validated questionnaires in a population of medical students in Bogota, Colombia, and its relationship with demographic characteristics, academic performance, depressive symptoms and substance use.

MATERIALS AND METHODS
=====================

Study design
------------

Cross-sectional prevalence study in medical students of the School of Medicine at the Pontificia Universidad Javeriana, in Bogota, Colombia, during 2013. We included students with complete academic load, with academic duties within the city (i.e., preclinical lectures or clinical rotations), and who were at University campus when the survey was applied. No sample size was calculated, as the study was developed as a census. We excluded medical students on their last year of education (i.e., eleventh and twelfth semesters), on the basis that the tasks and schedules during this internship year hold more resemblance to those of the practicing physician than to the normal work dynamics of the medical student. All participants (99.9%) were over 16 years old and were considered adults, as they were in a university program. Moreover, sleep disorder questionnaires have been found to be reliable among university students^[@r30]^.

Applied instruments
-------------------

Sleep quality was determined using PSQI Colombian-validated version^[@r31]^ which discriminates between good and bad sleepers. A score of more than 5 define bad sleepers.

Daytime sleepiness was assessed using ESS Colombian-validated version^[@r32]^, which determine the chance of falling asleep in 8 different circumstances. Although it has been considered a useful tool for OSA screening, in a previous study, we did not find a correlation with OSA severity^[@r33]^. Nevertheless, it is regarded as a significant symptom, which may point out to the existence of an altered sleep pattern.

The Berlin questionnaire (BQ) Colombian-validated version was used^[@r34]^ for the assessment of OSA risk in our population. The survey measures 3 categories: snoring, daytime sleepiness, and obesity and high blood pressure. In our scenario, the last domain was self-reported: students were asked to take their blood pressure and weight one day before the survey as an academic exercise, but no additional information was given. Positive results in two domains detect a high-risk individual. It has been shown useful in patients 15 years old or older^[@r35]^.

Regarding mood disorders, the *Diagnostic and Statistical Manual of Mental Disorders* (DSM) -IV diagnostic criteria were used. These criteria allow a major depression diagnosis when five out of nine criteria are present in the patient, provided depressed mood criterion is present^[@r36]^. Although DSM-V is available since May 2013, we applied its previous version as multiple controversies, particularly regarding false-positive diagnosis with DSM-V were suggested in the literature^[@r37]^. In addition, the study protocol was written and approved before this version was endorsed.

We selected questions concerning the frequency of use of the most often used substances during the last month, according to the "*National Survey on Psychoactive Substance Use in school-age population*", developed in 2011^[@r38]^, namely: energy drinks, alcohol, tobacco, marihuana, cocaine, stimulants (i.e., methylphenidate - Ritalin, methamphetamine - "Meth") and tranquilizers (i.e., diazepam, lorazepam, alprazolam, clonazepam, etc). Given the economic-dependence of our target population, we considered that the economic capacity to obtain substances was similar between school-age population and medical students. Regarding alcohol consumption, individual episodes of consumption greater than one drink in the last month and total episodes of binge drinking (i.e., inebriation) in the same period were included.

Colombian grading system ranges from 1.0 to 5.0, the latter being the highest possible. Self-reported cumulative and actual grade point average (GPA) were obtained. We used a quantitative scale with five possible categories: \<3.0, 3.0-3.4, 3.5-3.9, 4-4.4, \>4.5.

The described tools were condensed in a questionnaire, which was applied to each semester. Students were free to either participate or not in the study. Two researchers (PH and AR) were lecturers during undergraduate studies, but had no responsibilities to grade them. A computer-based survey method was used (TurningPoint v8.0 for Windows). Each student was given a wireless response clicker to answer the questions projected on a screen. As self-reported answers were to be obtained, no personal data were associated to each clicker and, thus, the researchers were unable to identify each student\'s answer.

A time frame of 10 seconds was given for each question, which was considered sufficient after a pilot application was performed among the authors. Each participant had only one chance to answer the survey. To reassure that individuals were not sampled more than once, the survey was applied prior to the beginning of a lecture that was exclusive for each semester. Participants could not see their fellow students\' answers.

Data analysis
-------------

The software yielded spreadsheets, which were analyzed using Graphpad Prism 7 for Mac. As variables were mainly categorical, absolute and relative frequencies were calculated. Chi square and Fisher\'s exact tests were used, as required. *P* values \< 0.05 were considered significant. As multiple comparisons were performed, Bonferroni\'s correction was applied to determine significant findings.

Ethical considerations
----------------------

The study protocol was reviewed and approved by the Research and Ethics Committee of the Pontificia Universidad Javeriana (FM-CIE-6086-13). The study was classified as a minimal risk research and conducted in agreement with Helsinki declaration, and the Resolution number 008430 of 1993 issued by the Ministry of Health of the Republic of Colombia.

RESULTS
=======

We obtained data from 544 medical students. [Table 1](#t1){ref-type="table"} shows the demographic characteristics of the surveyed medical student population. Due to the answering method (anonymous and elective), there were variations in the sub-group populations, as some of the participants were unwilling to answer some of the questions. Based on those missing answers, the number of participants changed from question to question. Fifty percent of the surveyed were between the ages of 19 and 21, and 54% were women. Sixty percent were on the preclinical study phase (i.e., first to fifth semester).

###### 

General characteristics of total surveyed population and by questionnaire.

  Variable \[n (%)\]                                                              Total (n=544)   PQSI (n=300) [\*](#TFN1){ref-type="table-fn"}   ESS (n=471) [\*](#TFN1){ref-type="table-fn"}   BQ (n=544) [\*](#TFN1){ref-type="table-fn"}   *p*-value
  ------------------------------------------------------------------------------- --------------- ----------------------------------------------- ---------------------------------------------- --------------------------------------------- -----------
  Age                                                                                                                                                                                                                                           
  \<16                                                                            5 (1)           4 (1)                                           5 (1)                                          5 (1)                                         0.96
  16-18                                                                           138 (25)        80 (27)                                         121 (26)                                       138 (25)                                      
  19-21                                                                           274 (50)        161 (54)                                        244 (52)                                       274 (50)                                      
  22-24                                                                           103 (19)        48 (16)                                         85 (18)                                        103 (19)                                      
  \>25                                                                            8 (2)           2 (1)                                           8 (2)                                          8 (2)                                         
  ND                                                                              16 (3)          5 (2)                                           8 (2)                                          16 (3)                                        
  Gender                                                                                                                                                                                                                                        
  Male                                                                            197 (36)        110 (37)                                        173 (37)                                       197 (36)                                      0.88
  Female                                                                          296 (54)        170 (57)                                        259 (55)                                       296 (54)                                      
  ND                                                                              51 (9)          20 (7)                                          39 (8)                                         51 (9)                                        
  Currently working                                                                                                                                                                                                                             
  Yes                                                                             15 (3)          10 (3)                                          10 (2)                                         15 (3)                                        0.25
  No                                                                              513 (94)        287 (96)                                        455 (97)                                       513 (94)                                      
  ND                                                                              16 (3)          3 (1)                                           6 (1)                                          16 (3)                                        
  Study stage                                                                                                                                                                                                                                   
  Preclinical                                                                     325 (60)        185 (62)                                        281 (60)                                       325 (60)                                      0.94
  Clinical                                                                        219 (40)        115 (38)                                        190 (40)                                       219 (40)                                      
  Fulfilled DSM-IV Depression Criteria (n=529) [\*](#TFN1){ref-type="table-fn"}                                                                                                                                                                 
  Yes                                                                             139 (26)        \-                                              \-                                             \-                                            \-
  No                                                                              390 (74)        \-                                              \-                                             \-                                            
  GPA (n=450) [\*](#TFN1){ref-type="table-fn"}                                                                                                                                                                                                  
  \<4                                                                             227 (50)        \-                                              \-                                             \-                                            \-
  \>4                                                                             223 (50)        \-                                              \-                                             \-                                            

Available complete questionnaires/answers.

Abbreviations: PSQI Pittsburgh Sleep Quality Index; ESS Epworth Sleepiness Scale; BQ Berlin Questionnaire; ND No data.

[Table 2](#t2){ref-type="table"} shows sleep patterns of the surveyed population. We collected 300 analyzable PQSI scores, where we found a poor sleep quality prevalence of 65.7%.

###### 

General characteristics by questionnaire score.

  Variable \[ n (%)\]   PSQI (n=300)[\*](#TFN3){ref-type="table-fn"}   ESS (n=471)[\*](#TFN3){ref-type="table-fn"}   BQ (n=544)[\*](#TFN3){ref-type="table-fn"}                                                                                                                        
  --------------------- ---------------------------------------------- --------------------------------------------- -------------------------------------------- ---------- ---------- ----------------------------------------- ---------- ----------------------------------------- -----------------------------------------
  Age                                                                                                                                                                                                                                                                                   
  \<16                  3 (75)                                         1 (25)                                        0.02                                         2 (40)     3 (60)     0.69                                      5 (100)    0 (0)                                     0.38
  16-18                 38 (47)                                        42 (53)                                       46 (38)                                      75 (62)    125 (91)   13 (9)                                                                                         
  19-21                 48 (30)                                        113 (70)                                      86 (35)                                      158 (65)   251 (92)   23 (8)                                                                                         
  22-24                 13 (27)                                        35 (73)                                       24 (28)                                      61 (72)    87 (85)    16 (15)                                                                                        
  \>25                  \-                                             2 (100)                                       3 (37)                                       5 (63)     7 (88)     1 (12)                                                                                         
  ND                    1 (20)                                         4 (80)                                        4 (50)                                       4 (50)     15 (94)    1 (6)                                                                                          
  Gender                                                                                                                                                                                                                                                                                
  Male                  42 (38)                                        68 (62)                                       0.25                                         73 (42)    100 (58)   0.036[\*\*](#TFN4){ref-type="table-fn"}   167 (85)   30 (15)[\#](#TFN5){ref-type="table-fn"}   0.028[\*\*](#TFN4){ref-type="table-fn"}
  Female                52 (31)                                        118 (69)                                      75 (29)                                      184(71)    275 (93)   21 (7)[\#](#TFN5){ref-type="table-fn"}                                                         
  ND                    9 (45)                                         11 (55)                                       17 (44)                                      22 (56)    48 (94)    3 (6)                                                                                          
  Currently working                                                                                                                                                                                                                                                                     
  Yes                   2 (20)                                         8 (80)                                        0.62                                         4 (40)     6 (60)     0.94                                      14 (93)    1 (7)                                     0.80
  No                    100 (35)                                       187 (65)                                      159 (35)                                     296 (65)   461 (90)   52 (10)                                                                                        
  ND                    1 (33)                                         2 (67)                                        2 (33)                                       4 (67)     15 (94)    1 (6)                                                                                          
  Study stage                                                                                                                                                                                                                                                                           
  Preclinical           68 (37)                                        117 (63)                                      0.26                                         107 (38)   174 (62)   0.09                                      297 (91)   28 (9)                                    0.21
  Clinical              35 (30)                                        80 (70)                                       58 (30)                                      132 (70)   193 (88)   26 (12)                                                                                        

Available complete questionnaires.

Significant after Bonferroni\'s correction.

After a significant p-value by Chi square test was obtained, Fisher\'s exact test was performed to determine which subgroups differed significantly.

\*\*Values were calculated on available questionnaires for both variables.

Abbreviations: PSQI Pittsburgh Sleep Quality Index; ESS Epworth Sleepiness Scale; BQ Berlin Questionnaire; ND No data

A higher frequency of poor sleep quality was observed in 19-21 and 22-24 groups, compared with 16-18 group. No difference was observed regarding gender. Poor sleep quality was above 50% in every semester and no difference was observed between them (*p*=0.4685) ([Figure 1](#f1){ref-type="fig"}). Prevalence of daytime sleepiness, measured by ESS (n=471), was 65% using a 10 points cut-off. Women showed a significant higher frequency of daytime sleepiness (*p*=0.036). No difference was observed regarding age group. The proportion of students with high risk of OSA, according to the BQ (n=544), was 9.9%, which was significantly more frequent in men. No difference was observed regarding age group. Neither work status nor study stage showed significant differences in any scale.

Figure 1Distribution of PSQI by semester. A score of more than 5 in Pittsburgh Sleep Quality Index (PSQI) define bad sleepers.

A significantly higher frequency of daytime sleepiness was observed in students with poor sleep quality (*p*=0.0002). However, no difference was obtained concerning high risk of OSA (*p*=0.2578).

Regarding academic performance, 50% of the population reported an overall GPA above 4.0 ([Table 1](#t1){ref-type="table"}). However, as shown in [Figure 2](#f2){ref-type="fig"} and [Table 3](#t3){ref-type="table"}, poor overall academic performance was associated with poor sleep patterns. GPA \>4 were more frequent in students with PSQI \<5 (67% *vs.* 43%, *p*=0.001; OR=2.6 \[1.5-4.5\]), ESS \<10 (62% vs 45%, *p*=0.002; OR=2 \[1.3-3.1\]), and low risk BQ (52% *vs.* 26%, *p*=0.002; OR=3.1 \[1.6-5.9\]).

Figure 2Depressive symptoms and GPA\>4 distribution by PSQI. Solid line denotes depressive symptoms. Dotted line denotes GPA \>4. Abbreviations: GPA Grade Point Average, PSQI Pittsburgh Sleep Quality Index.

###### 

Depressive symptoms and GPA score by questionnaire score.

  Variable                                                PSQI (n=296)[\*](#TFN8){ref-type="table-fn"}   Epworth (n=464)[\*](#TFN8){ref-type="table-fn"}   Berlin (n=529)                                                                                                                      
  ------------------------------------------------------- ---------------------------------------------- ------------------------------------------------- -------------------------------------------- ---------- ---------- ----------------------------------------- ---------- ----------- -----------------------------------------
  n (%)                                                   \<5                                            \>5                                               *p*-value                                    \<10       \>10       *p*-value                                 Low risk   High risk   *p*-value
  Fulfilled DSM-IV Depression Criteria                                                                                                                                                                                                                                                          
  Yes                                                     4 (4)                                          117 (40)                                          \<0.0001[\*\*](#TFN9){ref-type="table-fn"}   26 (16)    98 (32)    0.001[\*\*](#TFN9){ref-type="table-fn"}   114 (24)   25 (47)     0.002[\*\*](#TFN9){ref-type="table-fn"}
  No                                                      97 (96)                                        78 (60)                                           135 (84)                                     205 (68)   362 (76)   28 (53)                                                          
  GPA                                                                                                                                                                                                                                                                                           
  \<4                                                     29 (33)                                        94 (57)                                           0.001[\*\*](#TFN9){ref-type="table-fn"}      52 (38)    145 (55)   0.002[\*\*](#TFN9){ref-type="table-fn"}   193 (47)   34 (74)     0.002[\*\*](#TFN9){ref-type="table-fn"}
  \>4                                                     59 (67)                                        72 (43)                                           86 (62)                                      119 (45)   211 (52)   12 (26)                                                          
  Total Available (%)^[+](#TFN10){ref-type="table-fn"}^   254 (86)                                       402 (87)                                          450 (85)                                                                                                                            

Available complete questionnaires.

Significant after Bonferroni\'s correction.

As some individuals did not answer all the questions, only complete questionnaires with available GPA were included.

Regarding DSM-IV Depression Criteria all data were available.

Abbreviations: GPA Grade point average; PSQI Pittsburgh Sleep Quality Index; ESS Epworth Sleepiness Scale; BQ Berlin Questionnaire; ND No data.

As shown in [Table 1](#t1){ref-type="table"}, we found a high frequency of students fulfilling DSM-IV criteria for major depression (26%), with a particularly dramatic share in the poor sleep quality population (PSQI \>5) compared with good sleepers (40% *vs.* 4%, *p*\<0.0001) ([Figure 2](#f2){ref-type="fig"}, [Table 3](#t3){ref-type="table"}). Further, this finding was reproduced in students with daytime sleepiness (ESS\>10 32% *vs.* 16%, *p*=0.001), and high risk of OSA (47% *vs.* 24%, *p*=0.002).

As disclosed in [Figure 3](#f3){ref-type="fig"}, we conducted an analysis of the prevalence of self-reported psychoactive substance use in the last month. Overall prevalence of alcohol use in at least one occasion was 79%; thirty-two percent of students reported one or more episodes of binge drinking. Energy drink usage was reported by 32% of the surveyed, whereas tobacco use was disclosed by 19% of the population ([Table 4](#t4){ref-type="table"}).

Figure 3Substance exposure at least once in the last month. Stimulants include methylphenidate - Ritalin, methamphetamine - "Meth". Tranquilizers include diazepam, lorazepam, alprazolam, clonazepam, etc.

###### 

General characteristics by substance[\*](#TFN12){ref-type="table-fn"}.

  Variable\[n (%)\]     Tobacco (n=530)   Alcohol (n=509)   Binge drink(n=524)   Energy drinks(n=516)   Marihuana (n=526)   Cocaine(n=524)   Stimulants^[+](#TFN13){ref-type="table-fn"}^ (n=528)   Tranquilizers^[+](#TFN13){ref-type="table-fn"}^ (n=532)
  --------------------- ----------------- ----------------- -------------------- ---------------------- ------------------- ---------------- ------------------------------------------------------ ---------------------------------------------------------
  General popu-lation   103 (19)          402 (79)          197 (38)             166 (32)               52 (10)             4 (0.8)          12 (2)                                                 11 (2)
  Age                                                                                                                                                                                                
  \<16                  \-                4 (1)             2 (40)               3 (2)                  1 (2)               \-               \-                                                     \-
  16-18                 19 (18)           90 (22)           50 (37)              35 (21)                11 (21)             2 (50)           1 (8)                                                  3 (27)
  19-21                 52 (50)           208 (52)          100 (37)             78 (47)                32 (62)             2 (50)           6 (50)                                                 3 (27)
  22-24                 27 (26)           84 (21)           40 (42)              46 (28)                7 (14)              \-               5 (42)                                                 5 (45)
  25 +                  3 (3)             6 (2)             2 (25)               2 (1)                  \-                  \-               \-                                                     \-
  ND                    2 (2)             10 (3)            3 (25)               2 (1)                  1 (2)               \-               \-                                                     \-
  Gender                                                                                                                                                                                             
  Male                  51 (50)           162 (40)          90 (47)              71 (43)                29 (56)             2 (50)           6 (50)                                                 5 (45)
  Female                45 (44)           203 (51)          92 (32)              77 (46)                17 (33)             2 (50)           5 (42)                                                 5 (45)
  ND                    7 (7)             37 (9)            15 (34)              18 (11)                6 (12)              \-               1 (8)                                                  1 (9)
  Study stage                                                                                                                                                                                        
  Preclinical           56 (54)           232 (58)          118 (38)             88 (53)                34 (65)             3 (75)           6 (50)                                                 6 (54)
  Clinical              47 (46)           170 (42)          79 (37)              78 (47)                18 (35)             1 (25)           6 (50)                                                 5 (45)

Every exposure is measured as at least one episode in the last month. Only available responses were included, which explains the difference in sample sizes for each substance.

Stimulants includes Methylphenidate - Ritalin, Methamphetamine - \"Meth\"; Tranquilizers includes Diazepam, Lorazepam, Alprazolam, Clonazepam, etc.

Abbreviations: ND No data.

Students with PSQI \>5 reported a more frequent consumption of energy drinks (37% *vs.* 17%, *p*=0.002). Those with high risk BQ exposed a high usage of energy drinks (47% *vs.* 30%) and marihuana (21% *vs.* 9%), although these findings were not significant after correction. Overall prevalence of both alcohol or tobacco use, were not different between groups ([Table 5](#t5){ref-type="table"}).

###### 

Substance use at least once in the last month by questionnaire score[\*](#TFN15){ref-type="table-fn"}.

  Variable                                          PSQI      *p*-value   Epworth                                    *p*-value   Berlin     *p*-value                        
  ------------------------------------------------- --------- ----------- ------------------------------------------ ----------- ---------- ----------- ---------- --------- --------
  Tobacco                                           14 (14)   42 (21)     0.1187                                     26 (16)     60 (20)    0.3807      88 (18)    15 (28)   0.1052
  Alcohol                                           77 (79)   145 (77)    0.7639                                     123 (78)    226 (78)   0.9055      357 (78)   45 (86)   0.2079
  Binge drink                                       30 (29)   79 (40)     0.0757                                     50 (31)     121 (40)   0.0682      176 (37)   21 (40)   0.7662
  Energy drinks                                     18 (17)   72 (37)     0.002[\*\*](#TFN16){ref-type="table-fn"}   42 (26)     101 (34)   0.0730      142 (30)   24 (47)   0.0260
  Marihuana                                         6 (6)     21 (11)     0.2046                                     16 (10)     28 (9)     0.8691      41 (9)     11 (21)   0.0112
  Cocaine                                           \-        2 (1)       0.5461                                     \-          2 (1)      0.5432      4 (1)      \-        0.9999
  Stimulants^[+](#TFN17){ref-type="table-fn"}^      \-        6 (3)       0.964                                      3 (2)       8 (3)      0.7542      10 (2)     2 (4)     0.3344
  Tranquilizers^[+](#TFN17){ref-type="table-fn"}^   \-        4 (2)       0.3022                                     3 (2)       6 (2)      0.9999      11 (2)     \-        0.6136

Values were calculated on available questionnaires for both variables.

Significant after Bonferroni\'s correction

Stimulants includes Methylphenidate - Ritalin, Methamphetamine - \"Meth\"; Tranquilizers includes Diazepam, Lorazepam, Alprazolam, Clonazepam, etc.

Abbreviations: PSQI Pittsburgh Sleep Quality Index; ESS Epworth Sleepiness Scale; BQ Berlin Questionnaire; ND No data.

DISCUSSION
==========

Poor sleep quality is present in up to two-thirds of medical students and is more frequent in those with daytime sleepiness. Furthermore, it appears to be associated with reduced academic performance, depressive symptoms and substance use.

The proportion of women in our study is in line with the gender distribution in Bogota (56%) according to data (2001-2014) from the Colombian Ministry of Education^[@r39]^. A significant proportion of our population presents poor sleep quality. This finding has been reported worldwide^[@r8]^. In our region, Cardoso et al. reported a prevalence close to 14%, in contrast to studies in Peru, which found a prevalence ranging from 60%^[@r40]^ to 90%^[@r41]^. A recent study in Brazil reported altered PSQI scores in up to 70% of medical students^[@r42]^. In Colombia, a prevalence as high as 88% has been reported^[@r24]^. Further, our results support the evidence of poor sleep quality in medical students in public and private schools in Colombia. Escobar-Córdoba et al.^[@r25]^ and Machado-Duque et al.^[@r43]^ reported a prevalence of up to 80% of poor sleep quality in public universities in Colombia. Similar results support that medical students\' populations in Latin America are akin to each other regarding their demanding curricula. Differences in socioeconomic characteristics between public and private universities seem to be unrelated to poor sleep quality. A relationship between chronic illnesses (i.e., asthma, diabetes, hypertension) and poor sleep quality has been described in medical students^[@r44]^, which may be a subject for future research.

Two-thirds of our medical student population present daytime sleepiness that warrants medical intervention (i.e., ESS \>10). Previous reports have shown similar results worldwide^[@r8]^, although our findings seem slightly higher. A study in Saudi Arabia showed a prevalence of 36%^[@r20]^, similar to the prevalence in Argentina^[@r45]^ and Peru^[@r40]^. In contrast, higher levels have been reported in Brazil (39% to 50%)^[@r46],[@r47]^ and Colombia (up to 60%)^[@r24]-[@r26],[@r43],[@r48]^. Daytime sleepiness tends to get worse with each semester, which may induce students to decreased attention and performance, and may be associated with diminished academic results^[@r46],[@r49]^.

One in ten students may present OSA, which reduces quality of sleep and may pose a potential health threat. Data regarding OSA risk in medical students and physicians is scarce; BQ has not been previously applied to these populations. In contrast to our results, Lucero et al.^[@r45]^ showed, using SLEEP-50 score, a prevalence of 0.32% in Argentinian medical students. Although a large portion of general population might be at high risk of OSA^[@r50]^, a Nigerian study found that knowledge on OSA in medical students warrants improvement, and suggested to formally incorporate the evaluation of sleep disorders in undergraduate curricula^[@r51]^. This phenomenon has been reported in primary care physicians in Latin America^[@r52]^. Our findings support the need for further research on OSA risk in medical students and health-care workers, which may impair professional and academic performance, and pose a potential risk for health^[@r50]^.

Poor sleep quality is associated with daytime sleepiness and OSA. Cardoso^[@r47]^ previously described a significant relation between daytime sleepiness and poor sleep quality in medical students. In addition, a positive trend was found in Nigeria^[@r44]^.

Poor sleep quality and daytime sleepiness prevalence is similar in both preclinical and clinical years in our population, which agrees with previous reports^[@r40],[@r48]^. Our findings support the importance of identification of the population at-risk of sleep disturbances in early-years of medicine school and the implementation of targeted interventions.

Our results show that 1 in 4 students presents depressive symptoms, which are associated with poor sleep quality, daytime sleepiness and high risk of OSA. The relationship between mood and anxiety disorders and sleep disturbances is clear^[@r8]^. A study at Johns Hopkins School of Medicine found that insomnia posed a greater risk for clinical depression, which may last up to 30 years^[@r53]^ Moreover, Hidalgo & Caumo^[@r54]^ reported a higher risk for developing minor psychiatric disorders in Brazilian medical students with sleepiness, insomnia or less than 7 hours per night of sleep, which was further reproduced using a different questionnaire^[@r55]^. Loayza et al.^[@r55]^ suggested insomnia screening "might be a good tool for the identification of medical students who could benefit from psychiatric assessment and preventive measures". Some researchers have even related subjective poor sleep quality with an increased risk of suicide^[@r56]^. On the other hand, daytime sleepiness was associated with depression and anxiety in an Estonian cohort of medical students^[@r57]^ and was found to be related to psychological distress in Malaysia^[@r58]^ However, it is known that sleep disturbances may be a comorbidity, a symptom or even a cause of psychiatric disorders^[@r59]^. The role of sleep quality in medical students should be addressed with curricula modifications processes to prevent potential mental health issues in future health-care workers.

Some researchers described a significant relation between daytime sleepiness and academic performance^[@r20],[@r45]^ as we did using a GPA cutoff point of 4.0. However, evidence is conflicting^[@r24],[@r25],[@r43],[@r60]^. Our results suggest that students with good sleep quality, low daytime sleepiness or low risk of OSA might present a better academic performance. This was described previously by Veldi et al.^[@r22]^, who ascertained poor sleep quality correlated with lower academic achievements, although non-validated questionnaires were used.

Due to chronic sleep deprivation, medical students may be prone to psychotropic substance use. Substance use is frequent among medical students and is significantly associated to living alone, self-reported study difficulty and being a clinical student, whereas self-reported good mental health might be a protective factor^[@r61]^ Young people may present a higher frequency of alcohol or stimulant agents consumption in order to regulate sleep/wake cycle^[@r8]^. This behavior favors the use of stimulant to halt daytime sleepiness, and subsequently promotes the use of sedative agents to revert its effects, phenomenon known as "*stimulant-sedation loop*"^[@r62]^ For instance, a study in Peru found that 20% of medical students had used sleep medications during the last month^[@r60]^. Further, frequent use of alcohol was significantly associated to poor sleep quality in Nigeria^[@r44]^. Our results highlight a frequent use of alcohol, energy drinks and tobacco. Noteworthy, marihuana use was frequent in students with high risk of OSA. Although energy drinks are not naturally a category of substance abuse as other drugs, they were the most frequently associated with poor sleep patterns; no associations were found with alcohol or tobacco consumption.

Despite these alarming findings, our study has some limitations. First, we describe a cross-sectional design that may depict sub-acute disturbances, despite the time frame considered in most of the applied questionnaires (i.e., the last month). Follow-up studies are warranted to determine the impact of bad sleep habits on medical students. Second, although our study was planned as a census, to survey every student in each semester was a challenge. This phenomenon was reflected in the variability of sample within each semester, which may somehow bias results. Nonetheless, the fact that no differences were detected between semesters supports the validity of the findings. Third, some students did not answer all the questions, which yielded a reduction in the number of complete questionnaires available for analysis. Although this probably may bias the results, we show the usefulness of a computer-based method using wireless response clickers for large samples self-reported assessment. This may facilitate data collection with an adequate reliability. Fourth, we acknowledge the self-application of DSM-IV may limit the external validity of the results. Alternative questionnaires would be more useful and comparable, such as Beck\'s Depression Inventory-II, which was adapted to DSM-IV and validated in Spanish in college students^[@r63],[@r64]^. Nonetheless, as acknowledged by the current DSM-5, depressive disorders are often accompanied by significant levels of anxiety. Thus, instruments that consider this feature may be more adequate for future research, such as the Patient Health Questionnaire Anxiety and Depression Scale^[@r65]^. In any case, we consider our data highlights the high frequency of depression among this population. Fifth, we did not capture relevant information such as that obtained through sleep logs and actigraphy, and neither applied a chronotype questionnaire. For instance, the latter could shed light into whether students with depressive mood were more frequently evening-type, a feature that should be explored. Further studies to screen and determine risk factors for mood disorders, that may allow targeted interventions, are warranted.

Our results support the fact that sleep disturbances are common among medical students. A higher prevalence, when compared with non-medical students and the general population, has been suggested^[@r8]^. It is essential to consider the effects of poor sleep in medical trainees on their physical and mental health, in order to improve their academic performance and quality of life^[@r8]^. Furthermore, the quality of health care delivery will improve and society overall could benefit.

CONCLUSION
==========

Poor sleep quality and daytime sleepiness are common in our medical student population, and are associated with a diminished academic performance, depressive symptoms and substance abuse. Students with high risk of OSA are more common than expected. Noteworthy, a significant portion of students present mood disorders, which warrant medical intervention. As previously suggested^[@r8]^, more research and initiatives towards the improvement of sleep quality and knowledge, the identification of students at risk, and the development of targeted programs are urgently needed. Strategies to guarantee healthcare professionals safety and performance in developing countries are pivotal to support the quality of healthcare delivery.
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